AzTrials
AzTrials

Pressure AreaNCT06838390

Microcurrent Versus Transcutaneous Electrical Nerve Stimulation on Pressure Ulcer

A study testing Microcurrent Therapy, Transcutaneous electrical nerve stimulation and physical therapy program in people with Pressure Area, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study was to evaluate which is more effective, microcurrent or transcutaneous electrical nerve stimulation, in treating pressure ulcers in elderly patients. Read more about this study

Who is it for?
Ages 40 to 60 years
Conditions the study is for
Pressure Area
What is being tested?
Microcurrent Therapy, Transcutaneous electrical nerve stimulation and physical therapy program
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteEgypt
Study dates
1 Feb 2023to 1 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Subject selection was done according to the following criteria:
  • Age range between 40 and 60 years.
  • Male and female patients will participate in the study.
  • All patients enrolled in the study had their informed consent.
  • Pressure ulcer grades were grade II and III.
  • A relative or legal tutor provided consent when participants were incapable of making decisions.
  • The trial complied with the ethical principles of the Helsinki Declaration for medical research in humans.
  • Pressure ulcers were located in the sacral area

Who cannot join

  • Age less than 40 years or more than 60 years
  • A cardiac pacemaker or another implanted electric device.
  • Cognitive problems or hearing loss.
  • Pre-existing joint disorder before pressure ulcer.
  • Patients who have co-morbidities such as diabetes mellitus, rheumatoid arthritis, hypertension, and cardiac and renal patients,
  • Osteosynthesis implants near the ulcer, pressure ulcers in the occipital region, cancer, and osteomyelitis.
  • Abnormal blood markers at baseline indicating limited healing potential (anemia, iron deficit, protein deficit, dehydration, non-controlled diabetes, or hypothyroidism).
  • Allergy to the usual treatment for ulcer healing, systemic infection, and ulcer treatment with growth factor or vacuum-assisted closure in the 30 days before the Trial

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • out-patient clinic, faculty of physical therapy, Cairo university

    Cairo

Other trials in Egypt

About this study

The purpose of the study was to evaluate which is more effective, microcurrent or transcutaneous electrical nerve stimulation, in treating pressure ulcers in elderly patients.

Read the detailed description
  • Pressure sores are common problems in today's health care. A pressure sore leads to physiological as well as psychological suffering for the individual affected. The cost for the society, associated with prevention and treatment of pressure sores, is considerable
  • Furthermore, the need for this study was developed from the lack of quantitative knowledge and information in the published studies about the effect of microcurrent and transcutaneous electrical nerve stimulation in treating pressure ulcers in elderly patients.
  • This study will be carried out to provide guidelines about the effectiveness of microcurrent and transcutaneous electrical nerve stimulation in treating pressure ulcer and to assist in planning an ideal treatment regimen to increase healing of pressure ulcers in elderly patients.
Conditions
Pressure Area
Being tested
Microcurrent Therapy, Transcutaneous electrical nerve stimulation, physical therapy program, medial treatment
Keywords
Micro current versus TENs on pressure ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Microcurrent TherapyDevice

    The study uses a four-channel microcurrent therapy device to treat pressure ulcers. The treatment involves applying four electrodes to the area around the ulcer, ensuring microcurrent passage throughout the wound bed. The treatment is done three times a day, lasting 35-40 minutes. The microcurrents are delivered in a monophasic, pulsed, square-form wave pulse with a voltage of 21 mV, an intensity of 42 µA, and a current density of 4.2 µA/cm.

  • Transcutaneous electrical nerve stimulationDevice

    The study aimed to treat ulcers with TENS using a two-channel device, delivered three times a day, for 8 weeks. The device induced peripheral vasodilation and activate local blood flow, potentially promoting wound healing. The treatment was delivered using a pulse train duration of 300 ms, with an internal frequency of 100 Hz and a burst frequency of 2 Hz.

  • physical therapy programOther

    The physiotherapy program included circulatory circulatory exercises, stretching exercises, and ROM exercises.

  • medial treatmentDrug

    patients was given their drugs from their physicians

Study groups in NCT06838390
Study groupRoleWhat they receive
Microcurrent therapyExperimentalThis group included 22 patients with pressure ulcer who received microcurrent therapy 8 weeks (3times /daily) in addition to their physical therapy program (circulatory exercise,stretching exercise, and ROM ex.) and medical treatment
Receives: Device: Microcurrent Therapy; Other: physical therapy program; Drug: medial treatment
transcutaneous electrical nerve stimulationActive comparatorThis group included 22 patients with pressure ulcers who received transcutaneous electrical nerve stimulation 8 weeks (3 times daily) in addition to their physical therapy program (circulatory exercise, stretching exercise, and range of motion exercise) and medical treatment.
Receives: Device: Transcutaneous electrical nerve stimulation; Other: physical therapy program; Drug: medial treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of ulcers length x width using Pressure Ulcer Scale for Healing

    The Pressure Ulcer Scale for Healing is a tool used to measure ulcer healing. It assesses the length x width of the ulcer (measuring the greatest length-head to toe-and the greatest width-side to side-using a centimeter ruler). It scores from 0-surface area of 0 cm²-to 10-surface area >24 cm²); The total score of pressure ulcer healing is calculated by adding three sub-scores, ranging from 0 (completely healed) to 17 (worst wound state), and comparing it at each time point indicates improvement or deterioration.

    Measured: at baseline and after 8 weeks

  2. Assessment of ulcers exudate amount using Pressure Ulcer Scale for Healing

    The Pressure Ulcer Scale for Healing is a tool used to measure ulcer healing.It assesses exudate amount (classified as none: score 0; light: score 1; moderate: score 2; or heavy: score 3); The total score of pressure ulcer healing is calculated by adding three sub-scores, ranging from 0 (completely healed) to 17 (worst wound state), and comparing it at each time point indicates improvement or deterioration.

    Measured: at baseline and after 8 weeks

  3. Assessment of ulcers tissue type using Pressure Ulcer Scale for Healing

    The Pressure Ulcer Scale for Healing is a tool used to measure ulcer healing. It assesses tissue type (score 1: superficial wound with epithelial tissue; score 2: the wound is clean and contains granulation tissue; score 3: there is any amount of slough present; score 4:necrotic tissue is present). If the wound is closed, the score is 0.

    The total score of pressure ulcer healing is calculated by adding three sub-scores, ranging from 0 (completely healed) to 17 (worst wound state), and comparing it at each time point indicates improvement or deterioration.

    Measured: at baseline and after 8 weeks

Secondary outcomes (1)
  1. Evaluation of blood flow in both the major and the minor vessels of the body.

    Medical Doppler ultrasound is used in clinical adjustments to evaluate blood flow in major and minor vessels. It shows normal and abnormal sign waveforms using spectral Doppler technique, which is individual to each vessel. Understanding normal and abnormal diagnostics is crucial for operators and clinicians

    Measured: at baseline and after 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2025
  2. Study start1 Feb 2023
  3. Primary completion1 Nov 2023
  4. Study completion1 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06838390
Sponsor's protocol ID
Hajar-005204
Status last verified
Feb 2025
First submitted
16 Feb 2025
Last updated
20 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Microcurrent Therapy, Transcutaneous electrical nerve stimulation and physical therapy program in people with Pressure Area, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of ulcers length x width using Pressure Ulcer Scale for Healing (time frame: at baseline and after 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in